Frontiers in Integrative Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the intricate workings of the nervous system. Since its inception in 2007, this journal has become a key resource for researchers and professionals in the field, covering a wide range of topics including cellular and molecular neuroscience, cognitive neuroscience, and sensory systems. With a reputation bolstered by its open-access model, Frontiers in Integrative Neuroscience aims to promote expedient dissemination of high-quality research, ensuring that all findings are readily accessible to the scientific community and beyond. The journal has achieved a commendable recognition, ranking in the upper tiers of its respective categories according to Scopus, with a Q2 ranking in both cognitive neuroscience and sensory systems, and a Q3 ranking in cellular and molecular neuroscience. Based in Switzerland, it continues to be a pivotal platform for innovative research that shapes our understanding of neural dynamics, encouraging collaboration and knowledge exchange among scholars worldwide.

Psicologia Clinica dello Sviluppo, published by SOC ED IL MULINO in Italy, is a noteworthy journal that focuses on the expansive fields of clinical and developmental psychology. Since its inception in 1998, the journal has been committed to disseminating high-quality research that bridges theoretical frameworks and practical applications within these domains. With its ISSN 1824-078X and E-ISSN 1824-078X, the journal provides a platform for scholars to explore critical issues in psychological development and clinical practice. Despite recent rankings placing it in the fourth quartile across both Clinical Psychology and Developmental and Educational Psychology categories, the journal is dedicated to fostering a growing body of knowledge that can influence policy and practice. Researchers, professionals, and students will find valuable insights in its contents, contributing to the advancement of psychology as a science and a profession. The journal accepts submissions and actively encourages contributions that tackle contemporary challenges in the field.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, published by Springer/Plenum Publishers, is a premier academic journal dedicated to advancing knowledge in the field of autism and related developmental disorders. With an impressive impact factor reflecting its reputation for rigorous peer-reviewed research, this journal has firmly established itself within the Q1 category of Developmental and Educational Psychology, ranked #32 out of 360 journals in its category, placing it in the top 91st percentile. The journal covers a broad range of topics, including intervention strategies, developmental trajectories, and the neurobiology behind autism spectrum disorders, making it an essential resource for researchers, educators, and clinicians alike. Since its inception in 1979, the journal has maintained a commitment to disseminating significant findings that can contribute to better understanding and support for individuals with developmental disorders, promoting interdisciplinary dialogue and collaboration. While it is not offered as open access, the Journal of Autism and Developmental Disorders remains a vital platform for the dissemination of transformative research in this crucial area.

Research in Autism Spectrum Disorders, an esteemed journal published by ELSEVIER SCI LTD, is dedicated to advancing the understanding of autism spectrum disorders through innovative research and scholarly articles. Since its inception in 2007, the journal has carved out a distinguished place in the field, reflected in its robust 2023 Impact Factor and Q2 ranking in key categories such as Clinical Psychology, Developmental and Educational Psychology, and Psychiatry and Mental Health. By bridging the gap between research and practice, this journal serves as a vital resource for researchers, professionals, and students alike, fostering collaboration and knowledge-sharing among those dedicated to improving outcomes for individuals with autism. Featuring a broad scope that encompasses various aspects of autism research, the journal remains committed to publishing high-quality studies that drive the conversation forward in this critical area of study. Access options for the journal's content are available under the Elsevier guidelines, ensuring that pivotal research reaches a wide audience.

CONGENITAL ANOMALIES is a notable journal published by WILEY, dedicated to advancing the understanding of congenital disorders and anomalies through high-quality research and clinical insights. With an ISSN of 0914-3505 and an E-ISSN of 1741-4520, this journal has been a key resource for professionals in the fields of pediatrics, embryology, and developmental biology since its inception in 1973, although coverage discontinued in Scopus after 2019 due to evolving standards in publication. The journal is ranked in the 48th percentile in the domain of pediatrics, as well as in the 26th and 14th percentiles respectively for embryology and developmental biology, placing it among respected publications in its category. Although it does not currently offer open access options, its contributions remain vital for researchers, healthcare professionals, and students seeking up-to-date information on congenital anomalies, their origins, and potential interventions. With a commitment to fostering knowledge in this critical area of health science, CONGENITAL ANOMALIES continues to play an important role in the intersection of scientific research and clinical practice.

PSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

Autism Research, published by WILEY, is a premier academic journal dedicated to advancing the understanding of autism spectrum disorders (ASD) through high-quality research and clinical studies. With the ISSN 1939-3792 and E-ISSN 1939-3806, this journal has been integral to the field since its inception in 2008 and has been consistently ranked in the Q1 quartile across categories such as Genetics (clinical), Neurology (clinical), and various facets of Neuroscience. Holding prominent Scopus ranks, including #18 in Genetics (clinical) and #26 in General Neuroscience, Autism Research provides a vital platform for researchers, clinicians, and students alike to disseminate innovative findings and foster collaborations aimed at improving diagnosis and treatment strategies for individuals with autism. While not an open access journal, it offers a blend of insightful articles and impactful research that is essential for professionals seeking to stay at the forefront of this rapidly evolving field.

GENES BRAIN AND BEHAVIOR is a leading journal published by Wiley that focuses on the intricate interplay between genetic factors and behavioral neuroscience. With a robust ISSN of 1601-1848 and an E-ISSN of 1601-183X, this journal serves as a premier platform for innovative research that spans across multiple fields including genetics, neurology, and behavioral neuroscience. Recognized for its significant impact with a 2023 categorization of Q1 in Behavioral Neuroscience and Q2 in both Genetics and Neurology, GENES BRAIN AND BEHAVIOR asserts itself as an influential resource for scholars, practitioners, and students alike, facilitating the advancement of knowledge in these dynamic areas. Its Scopus rankings underscore its prominence—ranking #18 in Behavioral Neuroscience and #45 in Neurology, placing it in the top percentiles among its peers. Although not an open-access journal, the rigorous peer-review process ensures high-quality publications, pivotal for those pursuing cutting-edge research and applications. With a history of convergence from 2002 to 2024, this journal continues to foster academic dialogue and discovery in the ever-evolving landscape of brain and behavioral studies.

NEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.